Terazosin

Chemical formula: C₁₉H₂₅N₅O₄ Molecular mass: 387.433 g/mol PubChem compound: 5401

Therapeutic indications

Terazosin is indicated for:

Hypertension

Population group: only adults (18 years old or older)

Orally administered terazosin is indicated in adults for the treatment of mild to moderate hypertension. It may be used in combination with thiazide diuretics and/or other antihypertensive drugs or as sole therapy where other agents are inappropriate or ineffective. The hypotensive effect is most pronounced on the diastolic pressure.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1 mg once daily and 2-10 mg once daily thereafter

Urinary obstruction caused by benign prostatic hyperplasia (BPH)

Population group: only adults (18 years old or older)

Orally administered terazosin is indicated in adults as a therapy for the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia (BPH).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

1 mg once daily and 5-10 mg onde daily thereafter

Contraindications

Terazosin is contraindicated in the following cases:

History of micturition syncope

Micturition syncope

Known sensitivity to other alpha-adrenoceptor blockers

Alpha-adrenoceptor agonist allergy

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.